SC Daily- How Will TOOT Finish This Week?
SmallCapVoice Newsletter
%3D 10-22-10 Small Cap Daily by SmallCapVoice.com ————————————– Yesterday`s Top Performers ————————————– Company: Concordis Group, Inc. (Pink Sheets: CNGI) End of day:
Price: 0.32 Change (%): + 0.04 (14.29) Volume: 77,000 http://bit.ly/beKvEI —————————- Hot Stocks To Watch —————————- Company: Madison Ave. Media, Inc. (OTCBB: KHZM) End of day:
Price: 0.90 Change (%): + 0.10 (12.50) Volume: 1,750 http://bit.ly/9Z0XUe ——————————– Other Small Cap News ——————————– Company: Procera=AE Networks Inc. (NYSE Amex: PKT) http://bit.ly/b9UvjZ Procera Networks Ranked # 1 Fastest Growing Networking Company Revenue Growth of 7,794% During Five-Year Period Recognized by Prestigious Deloitte 2010 Technology Fast 500(TM) LOS GATOS, CA–(Marketwire – 10/20/10) – Procera=AE Networks Inc. (AMEX:PKT), a developer of Evolved Deep Packet Inspection (DPI) solutions providing traffic awareness, control and protection for complex networks, today announced that it ranked number 1 fastest growing networking company and number 19 overall on Technology Fast 500(TM), Deloitte`s ranking of 500 of the fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. Rankings are based on the percentage of fiscal year revenue growth during the period from 2005-2009. Procera Networks grew 7,794 percent during this period.
Read More >> http://yhoo.it/bx0nZj —————————————————————————- Company: Helix BioPharma Corp. (NYSE Amex: HBP) http://bit.ly/bXoxiI Helix BioPharma Corp. Reports Positive Efficacy and Safety Findings From Phase II Study of Its Topical Interferon Alpha-2b in Patients With Low-Grade Cervical Lesions After Treatment, 71.4% of the Women No Longer Had Potentially Pre-Cancerous Low-Grade CIN 1 or CIN 2 Cervical Lesions AURORA, ON–(Marketwire – 10/21/10) – Helix BioPharma Corp. (TSX:HBP) (AMEX:HBP) (Frankfurt:HBP), a biopharmaceutical company developing drug candidates for the prevention and treatment of cancer, today announced positive efficacy and safety findings from its recently completed Phase II pharmacokinetic study of Topical Interferon Alpha-2b in patients with low-grade cervical lesions. These findings build upon the positive pharmacokinetic findings from this study announced in the Company`s press release of June 23, 2010.
Read More >> http://yhoo.it/c2qEeB ——————————————————– Company: Paulson Investment Company, Inc. (Nasdaq: PLCC) http://bit.ly/cxxu7j Paulson Investment Company, Inc. Completes Public Offering for Healthy Fast Foods, Inc.
PORTLAND, OR–(Marketwire – 10/21/10) – Paulson Investment Company, Inc., a wholly owned subsidiary of Paulson Capital Corp. (NASDAQ:PLCC), today announced it served as lead manager on the recently completed secondary offering for Healthy Fast Foods, Inc. (OTC.BB:HFFI) (OTC.BB:HFFIU). The offering which closed on Thursday, October 21, 2010, had gross proceeds of $600,000.
Read More >> http://yhoo.it/dAabcL —————————————————————————— Company: Discovery Laboratories, Inc. (Nasdaq: DSCO) http://bit.ly/bFebz7 Discovery Labs Announces Presentation & Key Results of Phase 2a Study of Aerosolized KL4 Surfactant in Cystic Fibrosis at the North American Cystic Fibrosis Conference WARRINGTON, Pa., Oct. 22, 2010 (GLOBE NEWSWIRE) — Discovery Laboratories, Inc. (Nasdaq:DSCO) today announces that the Phase 2a clinical study of aerosolized KL4 surfactant (lucinactant) in patients with cystic fibrosis (CF) was presented at the 2010 North American Cystic Fibrosis Conference (NACFC).. The trial was conducted as an investigator-initiated study under the direction of Dr. Scott H. Donaldson at The University of North Carolina (UNC) with support from PARI Pharma GmbH, and was funded by Cystic Fibrosis Foundation Therapeutics, Inc., a nonprofit affiliate of the Cystic Fibrosis Foundation.
Read More >> http://yhoo.it/9E1b3d ——————————————————————————- Company: KeyCorp (NYSE: KEY) http://bit.ly/c6Vl21 KeyCorp posts 3Q profit of $178M KeyCorp has second-straight quarterly profit with $178 million in 3Q CLEVELAND (AP) — KeyCorp is reporting a profit for the third quarter in contrast to a loss a year ago, citing improved credit quality across its loan portfolios.
CEO Henry L. Meyer III says the bank has been working to lower its risk profile.
The Cleveland banking company said Friday that its net income available to shareholders amounted to $178 million, or 20 cents per share, in the three months ended Sept. 30. That easily beat Wall Street estimates of 3 cents per share.
Read More >> http://yhoo.it/bxlOEX ———————————————————————————- Company: Clarient, Inc. (Nasdaq: CLRT) http://bit.ly/cpLUpW GE Healthcare to Acquire Cancer Diagnostic Company Clarient Inc.
Addition of high-growth business will create strong technology-enabled services platform in molecular diagnostics CHALFONT ST GILES, UK and ALISO VIEJO, Calif., Oct. 22 /PRNewswire-FirstCall/ — GE Healthcare, a unit of General Electric Company (NYSE:GE), and Clarient, Inc. (Nasdaq:CLRT) announced today that they have entered into a definitive agreement for GE Healthcare to acquire Clarient, a leading player in the fast-growing molecular diagnostics sector. Clarient`s technologies, combined with GE Healthcare`s strengths in diagnostic imaging, are expected to accelerate the development of new integrated tools for the diagnosis and characterization of cancer. A subsidiary of GE will commence a tender offer for all outstanding common and preferred shares of Clarient at $5.00 per common share and $20.00 per preferred share, in each case payable in cash.
Read More >> http://yhoo.it/czSsOi —————————————————————————- Company: DayStar Technologies, Inc. (Nasdaq: DSTI) http://bit.ly/crSWo0 DayStar Announces Agreements to Extinguish Approximately $1 Million of Outstanding Debts DayStar CEO, Magnus Ryde, commented, “We are pleased to have Socius as a new financial partner as we pursue opportunities to manufacture our CIGS modules offshore. As we stated on July 22, 2010, we are pursuing partnerships to implement this strategy. Those potential partnerships, if consummated, could include joint ventures, licensing agreements, contract manufacturing agreements, a reverse merger with or an acquisition of DayStar. It is clear to us that we need to continue to restructure our balance sheet and reduce debt to achieve the best opportunity for increased shareholder value. We are making very significant progress on this important initiative.” Read More >> http://yhoo.it/dx4B0Z ————————————————————————– Company: Boston Scientific Corporation (NYSE: BSX) http://bit.ly/aXub26 Boston Scientific Announces CE Mark Approval for Expanded Indication of WallFlex=AE Biliary RX Stent Company`s fully covered metal stent now approved for use in treating benign biliary strictures “The WallFlex Biliary RX Fully Covered Stent has proved effective in the management of malignant biliary strictures, and I`m pleased that physicians in Europe and other CE Mark countries can now use this stent to treat benign biliary strictures,” said Professor Jacques Deviere, M.D., Ph.D., Hopital Erasme in Brussels. “The WallFlex Stent incorporates the latest innovations in self-expanding metal stent technology and may provide significant benefits as a less-invasive alternative to surgery in these patients.” Read More >> http://yhoo.it/d24Oae —————— MarketNews —————— By Al Yoon: Reuters Fannie and Freddie may need another $215 billion NEW YORK (Reuters) – Fannie Mae (OTC BB:FNMA) and Freddie Mac (OTC BB:FMCC) may need as much as $215 billion in additional capital from the Treasury through 2013 to offset losses and maintain a positive net worth, their federal regulator said on Thursday.
Fannie Mae and Freddie Mac, whose programs fund the lion`s share of all new home loans, are at the center of debate as Congress sets to overhaul a U.S.. mortgage finance system that contributed to the worst housing crisis since the 1930s.
The cumulative capital needs of the two housing finance giants, which were seized by the government in late 2008, will likely fall between $221 billion and $363 billion through 2013, the Federal Housing Finance Agency estimated.
Read More >> http://yhoo.it/ckWkPG —————————————————————- By Tomoko A. Hosaka: Associated Press Writer Currencies center stage as G20 gets under way G20 tasked with quelling currency battles as ministers warn risks to global economy GYEONGJU, South Korea (AP) — The U.S. pressed emerging nations to set targets to reduce their vast trade surpluses with the West, a plan that could see their currencies rise, as a global finance summit fumbled for ways to reduce tensions that threaten to escalate into a trade war.
U.S. Treasury Secretary Timothy Geithner`s proposals, outlined in a letter to the Group of 20 major developed and emerging nations, met with immediate resistance on the opening day of a two-day meeting of top finance officials. Japan`s Finance Minister Yoshihiko Noda on Friday called the idea of targets “unrealistic.” The gathering of G-20 finance ministers and central bank governors in the South Korean city of Gyeongju comes just two weeks after their meeting in Washington failed to iron out currency differences that have led to fears of a trade war that could trigger another economic downturn.
Read More >> http://yhoo.it/aJwQl8 ————————————— Research and Commentary ————————————— The American Dream — Real or Not The Readers Respond http://yhoo.it/aYtSAU ———————————— IMPORTANT DISCLAIMER ———————————— You are receiving this e-mail because you either opted into to our mailing list at smallcapvoice.com or at one of our Money Show exhibits. opt out at any time by clicking on the Safe
Related posts:
- SC Daily- TOOT Trades Nicely Again
- TOOT Up 60% in a Week Is FLMG Next?
- SC Daily- BLQN Is Smart Green Play. TTCS Issues News
- OTCPicks.com Stocks to Watch for Wednesday, October 13th
- Fannie Mae Freddie Mac Lead the Weekly Top 10 FNMA, FMCC, IDOI, BZCN,ENTI